Literature DB >> 19259807

Oxaloacetate decreases the infarct size and attenuates the reduction in evoked responses after photothrombotic focal ischemia in the rat cortex.

David Nagy1, Mate Marosi, Zsolt Kis, Tamas Farkas, Gabriella Rakos, Laszlo Vecsei, Vivian I Teichberg, Jozsef Toldi.   

Abstract

A traumatic brain injury or a focal brain lesion is followed by acute excitotoxicity caused by the presence of abnormally high glutamate (Glu) levels in the cerebrospinal and interstitial fluids. It has recently been demonstrated that this excess Glu in the brain can be eliminated into the blood following the intravenous administration of oxaloacetate (OxAc), which, by scavenging the blood Glu, induces an enhanced and neuroprotective brain-to-blood Glu efflux. In this study, we subjected rats to a photothrombotic lesion and treated them after the illumination with a single 30-min-long administration of OxAc (1.2 mg/100 g, i.v.). Following induction of the lesion, we measured the infarct size and the amplitudes of the somatosensory evoked potentials (SEPs) as recorded from the skull surface. The photothrombotic lesion resulted in appreciably decreased amplitudes of the evoked potentials, but OxAc administration significantly attenuated this reduction, and also the infarct size assessed histologically. We suggest that the neuroprotective effects of OxAc are due to its blood Glu-scavenging activity, which, by increasing the brain-to-blood Glu efflux, reduces the excess Glu responsible for the anatomical and functional correlates of the ischemia, as evaluated by electrophysiological evoked potential (EP) measurements.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19259807     DOI: 10.1007/s10571-009-9364-8

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  42 in total

1.  Facial nerve injury-induced disinhibition in the primary motor cortices of both hemispheres.

Authors:  T Farkas; J Perge; Z Kis; J R Wolff; J Toldi
Journal:  Eur J Neurosci       Date:  2000-06       Impact factor: 3.386

2.  Peripheral nerve injury influences the disinhibition induced by focal ischaemia in the rat motor cortex.

Authors:  Tamás Farkas; Eniko Racekova; Zsolt Kis; Szatmár Horváth; Jozef Burda; Jan Galik; József Toldi
Journal:  Neurosci Lett       Date:  2003-05-15       Impact factor: 3.046

Review 3.  Lesion evolution in cerebral ischemia.

Authors:  Tobias Back; Thomas Hemmen; Olaf G Schüler
Journal:  J Neurol       Date:  2004-04       Impact factor: 4.849

4.  Reversibility of transient focal cerebral ischemia evaluated by somatosensory evoked potentials in cats.

Authors:  H Minamide; H Onishi; J Yamashita; K Ikeda
Journal:  Surg Neurol       Date:  1994-08

5.  Interstitial concentrations of amino acids in the rat striatum during global forebrain ischemia and potassium-evoked spreading depression.

Authors:  Svetlana Molchanova; Peeter Kööbi; Simo S Oja; Pirjo Saransaari
Journal:  Neurochem Res       Date:  2004-08       Impact factor: 3.996

6.  Electrical stimulation of motor cortex in experimental cortical ischaemia: pyramidal responses at C5 and the surface EMG.

Authors:  X Liu; N M Branston; M Kawauchi; D A Jellinek; L Symon
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1992-06

Review 7.  Homeostasis of glutamate in brain fluids: an accelerated brain-to-blood efflux of excess glutamate is produced by blood glutamate scavenging and offers protection from neuropathologies.

Authors:  V I Teichberg; K Cohen-Kashi-Malina; I Cooper; A Zlotnik
Journal:  Neuroscience       Date:  2008-03-18       Impact factor: 3.590

8.  Correlation between peri-infarct DC shifts and ischaemic neuronal damage in rat.

Authors:  G Mies; T Iijima; K A Hossmann
Journal:  Neuroreport       Date:  1993-06       Impact factor: 1.837

9.  Perfusion and diffusion-weighted MR imaging for in vivo evaluation of treatment with U74389G in a rat stroke model.

Authors:  T B Müller; O Haraldseth; R A Jones; G Sebastiani; C F Lindboe; G Unsgård; A N Oksendal
Journal:  Stroke       Date:  1995-08       Impact factor: 7.914

Review 10.  Heme degradation by reactive oxygen species.

Authors:  Enika Nagababu; Joseph M Rifkind
Journal:  Antioxid Redox Signal       Date:  2004-12       Impact factor: 8.401

View more
  18 in total

1.  Amelioration of ischemic brain damage by peritoneal dialysis.

Authors:  María del Carmen Godino; Victor G Romera; José Antonio Sánchez-Tomero; Jesus Pacheco; Santiago Canals; Juan Lerma; José Vivancos; María Angeles Moro; Magdalena Torres; Ignacio Lizasoain; José Sánchez-Prieto
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

2.  Oxaloacetate activates brain mitochondrial biogenesis, enhances the insulin pathway, reduces inflammation and stimulates neurogenesis.

Authors:  Heather M Wilkins; Janna L Harris; Steven M Carl; Lezi E; Jianghua Lu; J Eva Selfridge; Nairita Roy; Lewis Hutfles; Scott Koppel; Jill Morris; Jeffrey M Burns; Mary L Michaelis; Elias K Michaelis; William M Brooks; Russell H Swerdlow
Journal:  Hum Mol Genet       Date:  2014-07-15       Impact factor: 6.150

Review 3.  Taming glutamate excitotoxicity: strategic pathway modulation for neuroprotection.

Authors:  Ming Jia; Steve A Noutong Njapo; Vaibhav Rastogi; Vishnumurthy Shushrutha Hedna
Journal:  CNS Drugs       Date:  2015-02       Impact factor: 5.749

4.  Insulin and glucagon share the same mechanism of neuroprotection in diabetic rats: role of glutamate.

Authors:  Rami Abu Fanne; Taher Nassar; Samuel N Heyman; Nuha Hijazi; Abd Al-Roof Higazi
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-06-15       Impact factor: 3.619

5.  Protective effects of a novel synthetic α-lipoic acid-decursinol hybrid compound in experimentally induced transient cerebral ischemia.

Authors:  Tae Hun Lee; Joon Ha Park; Jong-Dai Kim; Jae-Chul Lee; In Hye Kim; Yongbae Yim; Seul Ki Lee; Bing Chun Yan; Ji Hyeon Ahn; Choong Hyun Lee; Ki-Yeon Yoo; Jung Hoon Choi; In Koo Hwang; Jeong Ho Park; Moo-Ho Won
Journal:  Cell Mol Neurobiol       Date:  2012-07-20       Impact factor: 5.046

Review 6.  Inducible glutamate oxaloacetate transaminase as a therapeutic target against ischemic stroke.

Authors:  Savita Khanna; Zachary Briggs; Cameron Rink
Journal:  Antioxid Redox Signal       Date:  2015-01-10       Impact factor: 8.401

7.  Neuroprotection by glutamate oxaloacetate transaminase in ischemic stroke: an experimental study.

Authors:  Francisco Campos; Tomás Sobrino; Pedro Ramos-Cabrer; Bárbara Argibay; Jesús Agulla; María Pérez-Mato; Raquel Rodríguez-González; David Brea; José Castillo
Journal:  J Cereb Blood Flow Metab       Date:  2011-01-26       Impact factor: 6.200

Review 8.  Extracorporeal methods of blood glutamate scavenging: a novel therapeutic modality.

Authors:  Agzam Zhumadilov; Matthew Boyko; Shaun E Gruenbaum; Evgeny Brotfain; Federico Bilotta; Alexander Zlotnik
Journal:  Expert Rev Neurother       Date:  2015-04-12       Impact factor: 4.618

9.  Blood glutamate grabbing does not reduce the hematoma in an intracerebral hemorrhage model but it is a safe excitotoxic treatment modality.

Authors:  Andrés da Silva-Candal; Alba Vieites-Prado; María Gutiérrez-Fernández; Ramón I Rey; Bárbara Argibay; David Mirelman; Tomás Sobrino; Berta Rodríguez-Frutos; José Castillo; Francisco Campos
Journal:  J Cereb Blood Flow Metab       Date:  2015-03-04       Impact factor: 6.200

10.  Neuroprotective effect of oxaloacetate in a focal brain ischemic model in the rat.

Authors:  L Knapp; L Gellért; K Kocsis; Z Kis; T Farkas; L Vécsei; J Toldi
Journal:  Cell Mol Neurobiol       Date:  2014-05-08       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.